PCP
CLSD

Proficio Capital Partners’s Clearside Biomedical CLSD Stock Holding History

Proficio Capital Partners’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29
Closed -$1K – 1961
2019
Q1 		$1K Buy
+29
New +$575 ﹤0.01% 1488

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Proficio Capital Partners's CLSD Position: Q2 2019 in Review

Proficio Capital Partners sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 29 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in CLSD in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

  • Proficio Capital Partners reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 29 Clearside Biomedical shares in Q2 2019, an estimated $1K.
  • Proficio Capital Partners first reported a position in Clearside Biomedical in Q1 2019 and held it in 1 quarter.
  • Proficio Capital Partners's Clearside Biomedical position peaked at $1K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on Proficio Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.